MYCN and neuroblastoma: Collectively, these data indicate that blocking DHODH activity can suppress the growth of MYCN-amplified neuroblastoma cell lines in vitro and in vivo, suggesting that DHODH is a potential therapeutic target for MYCN-amplified neuroblastoma.